dc.contributor.author | Horwich, A | |
dc.contributor.author | Parker, C | |
dc.contributor.author | Kataja, V | |
dc.contributor.author | ESMO Guidelines Working Group | |
dc.date.accessioned | 2018-07-26T09:33:58Z | |
dc.date.issued | 2009-05 | |
dc.identifier.citation | Annals of oncology : official journal of the European Society for Medical Oncology, 2009, 20 Suppl 4 pp. 76 - 78 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/2156 | |
dc.identifier.eissn | 1569-8041 | |
dc.identifier.doi | 10.1093/annonc/mdp135 | |
dc.format | Print | |
dc.format.extent | 76 - 78 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.subject | ESMO Guidelines Working Group | |
dc.subject | Humans | |
dc.subject | Prostatic Neoplasms | |
dc.subject | Treatment Outcome | |
dc.subject | Follow-Up Studies | |
dc.subject | Health Planning Guidelines | |
dc.subject | Societies, Medical | |
dc.subject | Europe | |
dc.subject | Male | |
dc.title | Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. | |
dc.type | Other | |
rioxxterms.versionofrecord | 10.1093/annonc/mdp135 | |
rioxxterms.licenseref.startdate | 2009-05 | |
rioxxterms.type | Other | |
dc.relation.isPartOf | Annals of oncology : official journal of the European Society for Medical Oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 20 Suppl 4 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Horwich, Alan | |
dc.contributor.icrauthor | Parker, Chris | |